Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.28+0.08 (+6.67%)
Close on Nov 12, 2026Market cap $11.53MP/E –Yield –
Lisata Therapeutics statistics
80 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.47
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 8.37
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 5.09%
- 10.9%
- Shares Change (QoQ)
- 0.13%
- 0.51%
- Float
- 8M
- 49M
- Shares Held by Insiders
- 11.6%
- 12.1%
- Shares Held by Institutions
- 12.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 34,163
- –
- Short Interest Change
- 18.6%
- -0.76%
- Short % of Float
- 0.43%
- 9.04%
- Short % of Shares Outstanding
- 0.38%
- 6.30%
- Days to Cover
- 1.00
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $5.07
- –
- 52-Week Low
- $0.96
- –
- 20-Day Moving Average
- $1.05
- –
- 50-Day Moving Average
- $1.29
- –
- 200-Day Moving Average
- $2.88
- –
- Average True Range (14)
- $0.14
- –
- Price Change (1 Week)
- 29.1%
- 1.51%
- Price Change (1 Month)
- 25.5%
- -2.35%
- Price Change (3 Months)
- 17.4%
- -21.1%
- Price Change (6 Months)
- -58.4%
- -22.6%
- Price Change (YTD)
- -31.2%
- -22.6%
- Price Change (1 Year)
- -39.0%
- -20.7%
- Price Change (3 Years)
- -40.3%
- -27.4%
- Price Change (5 Years)
- -91.9%
- -77.3%
- Price Change (10 Years)
- -97.5%
- -62.7%
- Average Volume (10 Days)
- 177,382
- –
- Average Volume (20 Days)
- 118,206
- –
- Average Volume (90 Days)
- 249,613
- –
- Relative Volume
- 0.48
- 0.79
- Relative Strength Index (14)
- 58.5
- 44.7
- Volatility (1 Year)
- 130.5%
- 80.4%
- Beta (5 Years)
- 0.76
- 1.07
MarginsIndustry
- Pretax Margin
- -15008.0%
- -11.8%
- EBITDA Margin
- -16363.0%
- -27.7%
- FCF Margin
- -12323.0%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- -99.9%
- -51.2%
- Return on Assets (ROA)
- -80.8%
- -40.6%
- Return on Invested Capital (ROIC)
- -1644.8%
- -32.9%
- Return on Capital Employed (ROCE)
- -204.3%
- -38.0%
Financial positionIndustry
- Current Ratio
- 3.69
- 3.30
- Quick Ratio
- 3.50
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- -90.7%
- 7.01%
EfficiencyIndustry
- Asset Turnover
- 0.01
- 0.40
- Revenue Per Employee
- $4.76K
- $429.29K
- Profits Per Employee
- -$696.24K
- -$683.67K
- Employee Count
- 21
- 75
- WACC
- 8.79%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$15.01M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $10.44M
- $17.46M
- Net Cash Per Share
- $1.16
- $0.72
- Equity (Book Value)
- $8.24M
- $53.27M
- Book Value Per Share
- $0.91
- $1.50
- Tangible Book Value
- $7.84M
- $26.82M
- Working Capital
- $8.03M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- $0
- -$944.00K
- FCF Per Share
- -$1.37
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -126.8%
- -20.8%
- FCF Yield
- -106.8%
- -9.58%
- Buyback Yield
- -5.09%
- -0.73%
- Shareholder Yield
- -5.09%
- 0.00%
Taxes and interestIndustry
- Income Tax
- -$387.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -74.39
- 0.30
- Piotroski F-Score
- 1
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | LSTA | S&P 500 | Difference | LSTA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +21.9% | -2.7% | +24.6 pts | ||
| 3 months | +8.5% | -1.7% | +10.2 pts | ||
| Year to date | -31.2% | +11.9% | −43.1 pts | ||
| 1 year | -40.7% | +12.0% | −52.7 pts | ||
| 3 years | -41.0% | +78.2% | −119.2 pts | -16.1% | +21.2% |
| 5 years | -91.9% | +73.2% | −165.1 pts | -39.5% | +11.6% |
| 10 years | -97.5% | +309.6% | −407.1 pts | -30.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M LSTA shares were sold short on Oct 30, 2026, up 18.6% from the previous report, or 0.43% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 51.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 34,163 | +18.6% | 58,762 | 1.0 |
| Oct 15, 2026 | 28,797 | -26.9% | 151,189 | 1.0 |
| Sep 30, 2026 | 39,407 | -76.1% | 362,256 | 1.0 |
| Sep 15, 2026 | 164,953 | +16.3% | 189,466 | 1.0 |
| Aug 31, 2026 | 141,798 | +57.8% | 844,223 | 1.0 |
| Aug 14, 2026 | 89,867 | +59.5% | 78,742 | 1.1 |
| Jul 31, 2026 | 56,341 | -56.6% | 155,428 | 1.0 |
| Jul 15, 2026 | 129,920 | +24.0% | 46,167 | 2.8 |
| Jun 30, 2026 | 104,813 | +17.0% | 20,026 | 5.2 |
| Jun 15, 2026 | 89,589 | -27.8% | 201,155 | 1.0 |
| May 29, 2026 | 124,163 | +32.8% | 220,592 | 1.0 |
| May 15, 2026 | 93,493 | +33.1% | 31,249 | 3.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?